Sanofi India: Q1 FY26 Results Approved; New Chairman & Board Changes

Sanofi India Ltd's Board of Directors, at its meeting on April 28, 2026, approved the Unaudited Financial Results for the quarter ended March 31, 2026. Additionally, the Board noted the completion of tenure for Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat, effective April 29, 2026. Mr. Rahul Bhatnagar has been appointed as the new Chairman of the Board, effective April 30, 2026. The company also announced the reconstitution of its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and Corporate Social Responsibility Committee, effective April 30, 2026.